Stuart Moss
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 7
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
- Journals
- Nature (10 papers)Nature Medicine (3 papers)Nature Cancer (3 papers)Nature Communications (2 papers)Med (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Stuart Moss
24 papers receiving 4.9k citations
Stuart Moss's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.9k
- Cancer Research 707
- Immunology 715
- Infectious Diseases 623
- Genetics 596
Countries citing papers authored by Stuart Moss
This map shows the geographic impact of Stuart Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Moss more than expected).
Fields of papers citing papers by Stuart Moss
This network shows the impact of papers produced by Stuart Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Moss. The network helps show where Stuart Moss may publish in the future.
Co-authors
The 2 scholars most cited alongside Stuart Moss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution Hit paper breakdown → | 2017 | 1030 |
| 2 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 3 | Lung adenocarcinoma promotion by air pollutants Hit paper breakdown → | 2023 | 546 |
| 4 | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Hit paper breakdown → | 2018 | 510 |
| 5 | 2017 | 369 | |
| 6 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 268 |
| 7 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 8 | The evolution of lung cancer and impact of subclonal selection in TRACERx Hit paper breakdown → | 2023 | 192 |
| 9 | The evolution of non-small cell lung cancer metastases in TRACERx Hit paper breakdown → | 2023 | 159 |
| 10 | Genomic–transcriptomic evolution in lung cancer and metastasis Hit paper breakdown → | 2023 | 140 |
| 11 | 2021 | 126 | |
| 12 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 13 | 2022 | 93 | |
| 14 | 2023 | 90 | |
| 15 | 2020 | 75 | |
| 16 | 2023 | 72 | |
| 17 | Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma Hit paper breakdown → | 2025 | 65 |
| 18 | 2023 | 60 | |
| 19 | 2021 | 51 | |
| 20 | 2024 | 29 |
About Stuart Moss
Stuart Moss is a scholar working on Cancer Research, Oncology, Genetics, Infectious Diseases and Immunology, having authored 24 papers that have together received 5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Genetic Associations and Epidemiology (5 papers), COVID-19 Clinical Research Studies (3 papers), Lung Cancer Treatments and Mutations (2 papers), T-cell and B-cell Immunology (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Nutrition and Health in Aging (1 paper). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (707 citations), Immunology (715 citations), Infectious Diseases (623 citations) and Genetics (596 citations). Stuart Moss has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Leslie Citrome and Chris Graf. Their work appears in journals such as Nature, Nature Medicine, Nature Cancer, Nature Communications and Med.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.